Abstract
Peripheral vascular complications in diabetic patients are extremely variable. It has been suggested that they are related, in part at least, to accelerated blood coagulation. However, a simple test to monitor these changes in coagulability has not been previously described. This article reports that a test in which citrated blood, when incubated with either saline (control) or with endotoxin (to activate the extrinsic pathway) and then subjected to the determination of the recalcification time, can detect minute changes in coagulability. This technique showed that the recalcification times of both saline and endotoxin-incubated blood samples were significantly shorter in a majority of diabetic patients than in controls. These studies substantiate the significant incidence of hypercoagulability in diabetics.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- García Frade L. J., de la Calle H., Alava I., Navarro J. L., Creighton L. J., Gaffney P. J. Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res. 1987 Sep 1;47(5):533–540. doi: 10.1016/0049-3848(87)90358-6. [DOI] [PubMed] [Google Scholar]
- Jones R. L. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes. Diabetes. 1985 Sep;34(9):836–843. doi: 10.2337/diab.34.9.836. [DOI] [PubMed] [Google Scholar]
- Lyberg T., Ivhed I., Prydz H., Nilsson K. Thromboplastin as a marker for monocyte differentiation. Br J Haematol. 1983 Feb;53(2):327–335. doi: 10.1111/j.1365-2141.1983.tb02027.x. [DOI] [PubMed] [Google Scholar]
- Prydz H., Allison A. C. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost. 1978 Jun 30;39(3):582–591. [PubMed] [Google Scholar]
- Rao A. K., Goldberg R. E., Walsh P. N. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med. 1984 Jan;103(1):82–92. [PubMed] [Google Scholar]
- Spillert C. R., Lazaro E. J. Shortened endotoxin-activated clotting times in patients with carcinoma. Am Surg. 1987 Mar;53(3):164–166. [PubMed] [Google Scholar]